On groundbreaking discoveries from the Center for Applied Proteomics and Molecular based medicine at the George Mason University, is Ceres use Nanotrap – developed a spherical, carbon – based nanoparticles, to collect, concentrate, isolate and preserve found the smallest and scarcest molecules in body fluids – a set of applications in the diagnosis and treatment of disease, as well as applications in the sports screening, homeland security and environmental remediation track.
– ‘This is a significant leap forward in technology that combines with existing assay platforms an efficient, reliable an efficient, reliable and accurate method for critical diagnostic methods,’said Thomas Dunlap, Ceres ‘ chief executive officer. ‘There is no science in the world can receive the immediate, protect and stabilize molecules from body fluids and obtained. ‘.. The Nanotrap technology was under the direction of Lance Liotta and Emanuel Petricoin III, co-directors of the Mason Center, organizations of a joint research program with the Instituto Superiore di Sanita ` of Rome, Italy, the primary scientific arm developed by the Italian National Health Service and one of the most prestigious health institutions in Europe. Continue reading →